|
|
|
|
|
|
|
|
|
|
|
21.08.25 - 10:30
|
WindowMaster International A/S wins 9 contracts in North America (Cision)
|
|
|
Investor news no. 058 - 2025
After 2 very successful weeks, WindowMaster has won several projects across North America covering New York, California and Ontario:
· 1 school in New York City (refurbishment)
· 5 schools in Long Island, New York (refurbishment)
· 1 school in California (refurbishment)
· 1 university in Ontario, CN (newbuild)
· 1 office building in Toronto, CN (newbuild)
The projects are primarily featuring refurbishment of the existing window automation, except for the two Canadian projects both being newbuild with integration of WindowMasters advanced NV...
|
|
|
|
|
|
|
|
|
|
|
|
|
21.08.25 - 09:48
|
Gubra: Gewinnwarnung – Aktie unter Druck (Der Aktionaer)
|
|
|
Das dänische Unternehmen Gubra rechnet mit einem schwächeren Forschungsdienstleistungsgeschäft im zweiten Halbjahr. In der Folge kassiert die Gesellschaft die Ziele für 2025 deutlich. Doch das Hauptaugenmerk der Firma, die von einem Mega-Deal mit AbbVie im ersten Halbjahr profitieren konnte, liegt auf der eigenen Pipeline....
|
|
|
21.08.25 - 09:39
|
Novo Nordisk Buy (DPA-AFX)
|
|
|
FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Novo Nordisk auf "Buy" mit einem Kursziel von 600 dänischen Kronen belassen. Emmanuel Papadakis bewertete in einer am Donnerstag vorliegenden Studie das jüngste Nachrichtenaufkommen ......
|
|
|
|
|
|
|
21.08.25 - 08:57
|
Aquaporin announces results for first half 2025 (PR Newswire)
|
|
|
Company announcement No. 16/2025 Aquaporin A/S Nymøllevej 78 DK-2800 Kongens Lyngby aquaporin.com Company registration no.: DK28315694 KONGENS LYNGBY, Denmark, Aug. 21, 2025 /PRNewswire/ -- Aquaporin A/S (CPH: AQP) ("Aquaporin" or the "Company"), an innovative water technology company......
|
|
|
21.08.25 - 08:36
|
Second Quarter Report Q2-2025 (Cision)
|
|
|
The Company has advanced well with its planned activities
· Positive and clinical meaningful top-line results from Study 0202
· New US manufacturing technology transfer nearing completion
· CT001 dossier development for EMA submission; filled and validated 14. August
· Organisational development, promotion of M. Juhl to Executive Management
· Strengthening the financial position with a direct issue of DKK 14.6 mill
Cessatech A/S (“Cessatech” or the “Company”) today releases its results for the period 1 April – 30 June 2025. The second quarter report is available as an...
|
|
|
|
|
|
|
|
|
21.08.25 - 08:01
|
Interim report second quarter 2025 (Cision)
|
|
|
STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
STENOCARE A/S (“STENOCARE”) today announces its results for the period 01.01.2025 – 30.06.2025. The report, which has not been reviewed by the Company's auditors, is attached to this release and is also available on https://stenocare.com/investor-relations/
Thomas Skovlund Schnegelsberg, CEO of STENOCARE, comments:
”Break-even for a quarter the first time since 2019. Stenocare is beginning to see the benefits of its STENOCARE 3.0 strategy, with increasing sales and a positive EBITDA. The Q2 report shows momentum...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
